Holen Sie sich die Stockscreener-App
270.78
1.50%
-4.13
Handel nachbörslich:
270.78
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Cencora Inc Aktie (COR) Neueste Nachrichten
Cencora, Inc. (COR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Cencora hits 52-week low after guidance cut - MSN
Cencora, Inc. (COR) Stock Analysis: Healthcare Giant With A 29.80% Upside Potential - DirectorsTalk Interviews
Cencora Inc. stock (US15135B1017): new leadership move as former CEO returns as chair amid healthcar - AD HOC NEWS
BlackRock Mid-Cap Growth Equity Portfolio's Cencora Inc(COR) Holding History - GuruFocus
Cencora Inc (COR) Stock Up 3.6% and Still Undervalued -- GF Scor - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cencora, Inc. (COR) And Encourages Investors to Connect - ACCESS Newswire
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora raises earnings outlook on share repurchases - Seeking Alpha
Cencora Inc. stock (US15135B1017): guidance tweak and extra $2 billion buyback attract fresh attenti - AD HOC NEWS
Cencora: Board of Directors Authorized New Shr Repurchase Program to Purchase Up to Additional $2.0B of Stk >COR - Moomoo
Cencora Raises Fiscal 2026 EPS Outlook, Authorizes $2 Billion Share Buyback - Moomoo
Cencora revises forecast for 2026, approves $2 billion share buyback - marketscreener.com
$2 billion stock buyback: Cencora lifts 2026 earnings forecast - Stock Titan
Cencora Announces Updated Fiscal Year 2026 Financial Outlook - marketscreener.com
Cencora, Inc. announces an Equity Buyback for $2,000 million worth of its shares. - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc.COR - PR Newswire
Cencora stock (US15135B1017): transformation story after name change and solid earnings - AD HOC NEWS
COR's MWI Animal Health to merge with Covetrus in $3.5 billion deal - MSN
Cencora, Inc. authorizes a Buyback Plan. - marketscreener.com
Deals tracker: Medtronic to acquire SPR Therapeutics for $650M - Modern Healthcare
Cencora stock (US15135B1017): Earnings miss and legal probe weigh on shares - AD HOC NEWS
Cencora, Inc. (COR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Cencora stock (US15135B1017): Q2 miss, legal probe and what matters now for investors - AD HOC NEWS
Cencora stock (US15135B1017): dividend track record and legal investigation in focus - AD HOC NEWS
Investors can join fraud probe against Cencora after Q2 miss and revenue drop claims. - Pluang
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire Inc.
Cencora (COR) Emerges as a Healthcare Leader with Robust Fundamentals and Strategic Re-Rating - Insider Monkey
Cencora stock (US15135B1017): revenue miss, guidance tweak and share price pressure in focus - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cencora, Inc. (COR) And Encourages Stockholders to Connect - ACCESS Newswire
Cencora Inc. stock underperforms Wednesday when compared to competitors - MSN
Will Cencora’s (COR) Revenue Miss and Probes Change Its Margin-Expansion Narrative? - simplywall.st
The Top 5 Analyst Questions From Cencora’s Q1 Earnings Call - Yahoo Finance
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? - MSN
Is It Time To Revisit Cencora (COR) After The Recent Share Price Slump? - simplywall.st
Rosen Law Firm Encourages Cencora, Inc. Investors to Inquire About Securities Class Action Investigation – COR - Business Wire
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
Cencora stock (US15135B1017): pharma distributor reshapes portfolio after latest earnings - AD HOC NEWS
Wells Fargo Maintains Overweight Rating on Cencora (COR) - Insider Monkey
Cencora, Inc. Common Stock (NY: COR - FinancialContent
Cencora faces securities fraud probe after missing revenue targets and stock plunge. - Pluang
Cencora, Inc.: - marketscreener.com
Cencora Inc. stock (US15135B1017): dividend date and legal probe in focus for investors - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell? - TradingView
ETFs Investing in Cencora, Inc. Stocks - TradingView
0.15%
4.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):